Grant Skrepnek to Adult
This is a "connection" page, showing publications Grant Skrepnek has written about Adult.
Connection Strength
0.747
-
Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation. Adv Ther. 2023 Jan; 40(1):349-366.
Score: 0.088
-
Clinical and economic outcomes associated with hospitalizations for acute idiopathic pericarditis in the United States. Heart Lung. 2021 Nov-Dec; 50(6):825-831.
Score: 0.080
-
Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid Program. J Manag Care Spec Pharm. 2019 Nov; 25(11):1261-1267.
Score: 0.071
-
Career Skills Assessment in a Doctor of Pharmacy Curriculum. Am J Pharm Educ. 2018 09; 82(7):6300.
Score: 0.065
-
Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid. J Manag Care Spec Pharm. 2018 Jul; 24(7):664-676.
Score: 0.065
-
Health Care Service and Outcomes Among an Estimated 6.7 Million Ambulatory Care Diabetic Foot Cases in the U.S. Diabetes Care. 2017 07; 40(7):936-942.
Score: 0.060
-
Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA. BMJ Open. 2015 Sep 09; 5(9):e007368.
Score: 0.053
-
A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010. PLoS One. 2015; 10(8):e0134914.
Score: 0.053
-
Health care expenditures, hospitalizations, and productivity associated with cancer in US employer settings. J Occup Environ Med. 2012 Dec; 54(12):1453-60.
Score: 0.044
-
Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005 Mar; 25(3):325-34.
Score: 0.026
-
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Curr Med Res Opin. 2005 Feb; 21(2):261-70.
Score: 0.026
-
Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. Am J Cardiovasc Drugs. 2019 Apr; 19(2):185-193.
Score: 0.017
-
Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012-2016. Med Care. 2018 08; 56(8):727-735.
Score: 0.016
-
Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy. J Oncol Pharm Pract. 2019 Apr; 25(3):520-528.
Score: 0.016
-
HIV Pharmacist's Impact on Inpatient Antiretroviral Errors. HIV Med. 2016 11; 17(10):717-723.
Score: 0.014
-
Administration of first dose antibiotic in the ED in patients with minor skin and soft tissue infections. Am J Emerg Med. 2015 Sep; 33(9):1225-8.
Score: 0.013
-
Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. J Med Econ. 2013; 16(1):10-8.
Score: 0.011
-
Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma. Curr Med Res Opin. 2008 Mar; 24(3):859-67.
Score: 0.008
-
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Curr Med Res Opin. 2007 Feb; 23(2):245-50.
Score: 0.007
-
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. Curr Med Res Opin. 2007 Feb; 23(2):251-8.
Score: 0.007
-
Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007 Jan-Feb; 20(1):72-80.
Score: 0.007